# Isotopen Technologien München: Biopharma, Garching near Munich, Germany

> Isotopen Technologien München: Isotopen Technologien München is a holding company that owns biotechnology and radiopharmaceutical companies.

Source: https://millionrounds.com/startup/isotopen-technologien-m-nchen (Millionrounds; every figure on the page links to its filing or article)

Germany · [Biopharma startup](https://millionrounds.com/companies)

# Isotopen Technologien München

Isotopen Technologien München is a holding company that owns biotechnology and radiopharmaceutical companies.

Email

Funding reported Last round: Private equity

Biopharma Garching near Munich, Germany

Follow Isotopen Technologien München and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fisotopen-technologien-m-nchen)

Company summary

- **Founded:** 2004 22 years old
- **Team:** 501 201 to 1,000 people
- **Funding reported:** 676M as listed, currency not stated
- **Last round:** Private equity Jun 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Isotopen Technologien München has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Isotopen Technologien München raised

Funding, as reported

Reported in all **676M** in the source's currency

Rounds **8**

Last round **Private equity**

Last round date **Jun 2024**

Investors listed **13**

## Founders and team

From Isotopen Technologien München's own website: 8 on the team.

- **Alexander Pironi** Executive Vice President, Global Head of Radioisotopes
- **Roger Estafanos** Executive Vice President, Global Head of Radiopharmaceuticals
- **Annette Breunig** Chief People Officer ITM Group
- **Dr. Celine Wilke** Chief Medical Officer of ITM
- **Jutta Lehmann** Head of Global Quality of ITM Group
- **Kathleen Noonan** Head of Corporate Communications
- **Marc Scharrer** General Counsel, Head of Legal
- **Merle Wagner** Corporate Secretary & Compliance Officer

## On 5 portfolio pages

Investors who name them

- [Deutsche Invest capital Partners](https://millionrounds.com/fund/deutsche-invest-capital-partners)
- [Nextech Invest](https://millionrounds.com/fund/nextech-invest)
- [RV Invest](https://millionrounds.com/fund/rv-invest)
- [Capmont](https://millionrounds.com/fund/capmont)
- [DI Kapital](https://millionrounds.com/fund/di-kapital)

Each firm lists Isotopen Technologien München on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biopharma in Germany

Startups like it

- [**NVision Imaging Technologies** Ulm · founded 2015](https://millionrounds.com/startup/nvision-imaging-technologies)
- [**Cellca** founded 2005](https://millionrounds.com/startup/cellca)
- [**Amplifold** Munich](https://millionrounds.com/startup/amplifold)
- [**Actome** Freiburg Im Breisgau · founded 2016](https://millionrounds.com/startup/actome)
- [**c-LEcta** founded 2004](https://millionrounds.com/startup/c-lecta)
- [**CancerVAX Biotech** Santa Barbara · founded 2021](https://millionrounds.com/startup/cancervax-biotech)
- [**pluriSelect** Leipzig · founded 2006](https://millionrounds.com/startup/pluriselect)
- [**Invitris** Garching Bei Múnchen · founded 2022](https://millionrounds.com/startup/invitris)

## Is this your company?

Add your raise, your deck and your story, and put Isotopen Technologien München in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)